Integer (NYSE:ITGR) Stock Rating Upgraded by Zacks Research

Posted by Brenda Bartman on Jul 22nd, 2026

Integer (NYSE:ITGR – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

ITGR has been the topic of a number of other research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Citigroup upped their price objective on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Truist Financial increased their price objective on shares of Integer from $97.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, July 16th. Piper Sandler reiterated an “overweight” rating and issued a $97.00 target price (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Finally, KeyCorp reissued an “overweight” rating and set a $104.00 target price on shares of Integer in a research note on Tuesday. Four investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $97.00.

Read Our Latest Analysis on ITGR

Integer Stock Performance

Shares of ITGR stock opened at $96.05 on Monday. The company has a market capitalization of $3.26 billion, a P/E ratio of 23.95, a P/E/G ratio of 2.29 and a beta of 0.64. The business’s 50 day moving average is $91.97 and its two-hundred day moving average is $87.81. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77. Integer has a 12-month low of $62.00 and a 12-month high of $116.31.

Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Analysts expect that Integer will post 6.04 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. Salomon & Ludwin LLC boosted its stake in Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Integer by 48.1% during the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares during the last quarter. TD Private Client Wealth LLC increased its holdings in shares of Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 415 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in Integer by 135.5% during the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares during the last quarter. Finally, Arax Advisory Partners raised its holdings in Integer by 2,489.5% in the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 473 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

About Integer

(Get Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.